Musheng Zeng

Title: Innovations of Musheng Zeng in Tumor-targeting Peptides

Introduction

Musheng Zeng is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer research, particularly in the development of tumor-targeting peptides. His innovative work aims to enhance the diagnosis and therapy of tumors, showcasing the potential of targeted treatments in oncology.

Latest Patents

Musheng Zeng holds a patent for a tumor-targeting polypeptide and its applications. The patent describes a tumor-targeting peptide that comprises a typical motif with the general formula of: XX(Y/F)(D/E)(D/E)XX. This motif is selectively connected with 1-3 amino acids at the C-terminal and/or N-terminal. The peptide is designed to target tumor vessels and tumor cells effectively, allowing it to penetrate these cells for improved tumor diagnosis and therapy. He has 1 patent related to this groundbreaking invention.

Career Highlights

Musheng Zeng is affiliated with the Sun Yat-sen University Cancer Center, where he conducts his research and development activities. His work is pivotal in advancing the understanding of tumor biology and the creation of targeted therapeutic strategies.

Collaborations

Musheng Zeng collaborates with notable colleagues in his field, including Xing Zhang and Jun Wang. Their combined expertise contributes to the innovative research being conducted at the cancer center.

Conclusion

Musheng Zeng's contributions to the field of tumor-targeting peptides represent a significant advancement in cancer treatment. His innovative approach has the potential to improve patient outcomes and enhance the effectiveness of cancer therapies.